PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1521921-2	1992	The generation of lymphokine-activated killer (LAK) activity, induced by in vitro activation of PBM with interleukin 2 (IL 2), was significantly augmented 5 days after a single intravenous dose of 2 mg lentinan, when compared with that before lentinan injection.	Lentinan	202-210	interleukin 2	Homo sapiens	105-118	
1521921-2	1992	The generation of lymphokine-activated killer (LAK) activity, induced by in vitro activation of PBM with interleukin 2 (IL 2), was significantly augmented 5 days after a single intravenous dose of 2 mg lentinan, when compared with that before lentinan injection.	Lentinan	202-210	interleukin 2	Homo sapiens	120-124	
3496854-4	1987	Combination therapy with lentinan, cyclophosphamide and IL-2 may well be documented as a new rational chemo-immunotherapy in place of adoptive LAK therapy and the infusion of large amounts of IL-2 causing frequent detrimental side effects.	Lentinan	25-33	interleukin 2	Homo sapiens	192-196